Chardan Capital Reiterates Buy Rating for Tenaya Therapeutics (NASDAQ:TNYA)
Chardan Capital reaffirmed their buy rating on shares of Tenaya Therapeutics (NASDAQ:TNYA – Free Report) in a research report sent to investors on Thursday, Benzinga reports. They currently have a $20.00 price target on the stock. TNYA has been the topic of a number of other reports. HC Wainwright restated a buy rating and set […]